3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Head & Neck
1
Genitourinary
1
Breast
1
Conditions
Homologous Recombination Deficient Solid Tumors
1
Interventions
Cisplatin
42
Pemetrexed
31
Carboplatin
28
Nivolumab
21
pembrolizumab
19
Gemcitabine
19
atezolizumab
13
Etoposide
13
Injections
12
Ipilimumab
11
Cyclophosphamide
11
Radiotherapy
10
Oxaliplatin
10
Filgrastim
10
Docetaxel
10
Bevacizumab
10
tislelizumab
9
Vincristine
9
Specimen Handling
9
durvalumab
8
Paclitaxel
8
Capecitabine
8
tremelimumab
7
toripalimab
7
lenvatinib
7
Everolimus
7
spartalizumab
6
olaparib
6
niraparib
6
Vinorelbine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Drug Combinations
×
Other solid neoplasm
×
Clear all
NCT04983745
2023-12-21
DIDO
West Cancer Center
Phase 2
Unknown
30 enrolled